1.
Rev Med Interne
; 45(7): 453-454, 2024 Jul.
Article
in French
| MEDLINE
| ID: mdl-38845251
Subject(s)
Adrenergic beta-Antagonists , Coronary Angiography , Myocardial Infarction , Recurrence , Stroke Volume , Humans , Adrenergic beta-Antagonists/therapeutic use , Adrenergic beta-Antagonists/administration & dosage , Adrenergic beta-Antagonists/adverse effects , Myocardial Infarction/diagnosis , Myocardial Infarction/complications , Stroke Volume/physiology , Stroke Volume/drug effects , Ventricular Function, Left/physiology , Ventricular Function, Left/drug effects , Time Factors , Secondary Prevention/methods , Risk Factors
2.
Rev Med Interne
; 45(6): 395-396, 2024 Jun.
Article
in French
| MEDLINE
| ID: mdl-38755073
Subject(s)
Fatty Liver , Liver Cirrhosis , Humans , Liver Cirrhosis/diagnosis , Liver Cirrhosis/complications , Fatty Liver/diagnosis , Fatty Liver/pathology , Biopsy/methods , Liver/pathology , Liver/drug effects , Treatment Outcome , Metabolic Diseases/diagnosis , Placebos , Dose-Response Relationship, Drug
3.
Rev Med Interne
; 45(4): 251-252, 2024 Apr.
Article
in French
| MEDLINE
| ID: mdl-38388304
Subject(s)
Aspirin , Clopidogrel , Ischemic Attack, Transient , Ischemic Stroke , Platelet Aggregation Inhibitors , Recurrence , Secondary Prevention , Humans , Clopidogrel/administration & dosage , Clopidogrel/adverse effects , Clopidogrel/therapeutic use , Aspirin/administration & dosage , Aspirin/adverse effects , Aspirin/therapeutic use , Ischemic Attack, Transient/drug therapy , Ischemic Attack, Transient/prevention & control , Ischemic Stroke/drug therapy , Ischemic Stroke/prevention & control , Platelet Aggregation Inhibitors/administration & dosage , Platelet Aggregation Inhibitors/adverse effects , Platelet Aggregation Inhibitors/therapeutic use , Secondary Prevention/methods , Secondary Prevention/standards , Time Factors , Drug Therapy, Combination , Stroke/prevention & control , Stroke/etiology , Risk Factors , Treatment Outcome
4.
Rev Med Interne
; 45(3): 178-179, 2024 Mar.
Article
in French
| MEDLINE
| ID: mdl-38228454
Subject(s)
Cardiovascular Diseases , Diabetes Mellitus, Type 2 , Glucagon-Like Peptides , Myocardial Infarction , Stroke , Adult , Humans , Body Mass Index , Myocardial Infarction/epidemiology , Myocardial Infarction/drug therapy , Stroke/prevention & control , Diabetes Mellitus, Type 2/complications , Diabetes Mellitus, Type 2/drug therapy , Hypoglycemic Agents/therapeutic use
5.
Rev Med Interne
; 45(1): 55-56, 2024 Jan.
Article
in French
| MEDLINE
| ID: mdl-38142212
Subject(s)
Amikacin , Pneumonia, Ventilator-Associated , Humans , Amikacin/therapeutic use , Pneumonia, Ventilator-Associated/epidemiology , Pneumonia, Ventilator-Associated/prevention & control , Pneumonia, Ventilator-Associated/drug therapy , Respiration, Artificial/adverse effects , Incidence , Anti-Bacterial Agents/therapeutic use , Intensive Care Units
6.
7.
Rev Med Interne
; 44(7): 383-384, 2023 07.
Article
in French
| MEDLINE
| ID: mdl-37183146
8.
Rev Med Interne
; 44(6): 319-320, 2023 06.
Article
in French
| MEDLINE
| ID: mdl-37045658
Subject(s)
Cardiovascular Diseases , Diabetes Mellitus, Type 2 , Renal Insufficiency, Chronic , Humans , Kidney , Renal Insufficiency, Chronic/complications , Renal Insufficiency, Chronic/drug therapy , Renal Insufficiency, Chronic/epidemiology , Benzhydryl Compounds/adverse effects , Glucosides/adverse effects , Diabetes Mellitus, Type 2/complications , Diabetes Mellitus, Type 2/drug therapy , Cardiovascular Diseases/epidemiology , Cardiovascular Diseases/prevention & control , Cardiovascular Diseases/drug therapy , Hypoglycemic Agents/adverse effects
9.
Rev Med Interne
; 44(2): 98-99, 2023 02.
Article
in French
| MEDLINE
| ID: mdl-36610875
10.
Rev Med Interne
; 44(1): 48-49, 2023 01.
Article
in French
| MEDLINE
| ID: mdl-36443201
Subject(s)
Diabetes Mellitus, Type 2 , Dipeptidyl-Peptidase IV Inhibitors , Metformin , Humans , Hypoglycemic Agents/therapeutic use , Hypoglycemic Agents/pharmacology , Diabetes Mellitus, Type 2/complications , Diabetes Mellitus, Type 2/drug therapy , Metformin/therapeutic use , Metformin/pharmacology , Sitagliptin Phosphate/therapeutic use , Insulin Glargine/therapeutic use , Liraglutide/therapeutic use , Dipeptidyl-Peptidase IV Inhibitors/therapeutic use , Glucagon-Like Peptide 1/therapeutic use , Glycemic Control , Insulin/therapeutic use , Blood Glucose , Drug Therapy, Combination , Treatment Outcome
11.
Rev Med Interne
; 43(10): 634-635, 2022 10.
Article
in French
| MEDLINE
| ID: mdl-36123199
Subject(s)
Azetidines , COVID-19 Drug Treatment , Azetidines/therapeutic use , Humans , Purines/therapeutic use , Pyrazoles , Sulfonamides
12.
Rev Med Interne
; 43(7): 455-456, 2022 07.
Article
in French
| MEDLINE
| ID: mdl-35725935
13.
Rev Med Interne
; 43(4): 270-271, 2022 04.
Article
in French
| MEDLINE
| ID: mdl-35279350
Subject(s)
COVID-19 Drug Treatment , Adult , Antiviral Agents/therapeutic use , Hospitalization , Humans , Ritonavir/adverse effects , SARS-CoV-2
14.
Rev Med Interne
; 43(2): 128-129, 2022 Feb.
Article
in French
| MEDLINE
| ID: mdl-35012789
Subject(s)
Cardiovascular Diseases , Hypertension , Aged , Aged, 80 and over , Antihypertensive Agents/therapeutic use , Blood Pressure , Cardiovascular Diseases/drug therapy , Cardiovascular Diseases/epidemiology , Cardiovascular Diseases/prevention & control , Humans , Hypertension/drug therapy , Hypertension/epidemiology , Middle Aged , Treatment Outcome
15.
Rev Med Interne
; 42(11): 814-815, 2021 Nov.
Article
in French
| MEDLINE
| ID: mdl-34728091
16.
17.
Rev Med Interne
; 42(5): 369-370, 2021 May.
Article
in French
| MEDLINE
| ID: mdl-33838950
Subject(s)
Diabetes Mellitus, Type 2 , Overweight , Body Weight , Comorbidity , Diabetes Mellitus, Type 2/drug therapy , Glucagon-Like Peptides , Humans , Hypoglycemic Agents/therapeutic use , Life Style , Obesity/complications , Obesity/epidemiology , Obesity/therapy , Overweight/complications , Overweight/epidemiology , Overweight/therapy
18.
Rev Med Interne
; 42(3): 227-228, 2021 03.
Article
in French
| MEDLINE
| ID: mdl-33612319
Subject(s)
COVID-19 Vaccines/therapeutic use , COVID-19/therapy , Immunotherapy, Active/adverse effects , SARS-CoV-2/immunology , Adolescent , Adult , Aged , Aged, 80 and over , BNT162 Vaccine , COVID-19/epidemiology , COVID-19 Vaccines/adverse effects , Clinical Trials as Topic/methods , Clinical Trials as Topic/organization & administration , Clinical Trials as Topic/standards , Female , Follow-Up Studies , Humans , Immunotherapy, Active/methods , Immunotherapy, Active/statistics & numerical data , Male , Middle Aged , Pandemics , Patient Safety/standards , RNA, Messenger/adverse effects , RNA, Messenger/therapeutic use , SARS-CoV-2/genetics , Treatment Outcome , Young Adult
19.
Rev Med Interne
; 42(2): 144-145, 2021 Feb.
Article
in French
| MEDLINE
| ID: mdl-33455835
Subject(s)
Diabetes Mellitus, Type 2 , Renal Insufficiency, Chronic , Albuminuria/drug therapy , Diabetes Mellitus, Type 2/complications , Diabetes Mellitus, Type 2/drug therapy , Disease Progression , Humans , Naphthyridines , Renal Insufficiency, Chronic/complications , Renal Insufficiency, Chronic/drug therapy
20.
Rev Med Interne
; 42(1): 65-66, 2021 Jan.
Article
in French
| MEDLINE
| ID: mdl-33309055